Health
Economic burden of acute myeloid leukemia treatment | JBM – Dove Medical Press
What does the economic burden of acute myeloid leukemia treatment look like for the next decade? An analysis of key findings, challenges and recommendations
AML: A Rare and Costly Cancer
Acute myeloid leukemia (AML) arises in the bone marrow from the abnormal clonal expansion of myeloid blood cell precursors. Leukemic blast cells are found in the circulating blood as well as in the bone marrow, where they disrupt normal blood cell production, leading to myelosuppression.1 Consequences of AML include anemia, with weakness and pallor, thrombocytopenia, resulting in bleeding, and leukopenia, leading to fever and infection.
AML, which accounts for about…
-
Business13 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General10 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Noosa News24 hours agoQueensland’s bid for net zero by 2050 unlikely under new energy plan: expert
-
General22 hours agoWestern Bulldogs extend Essendon’s losing streak with 57 point thrashing